Nikolaos V. Angelis

Athens, ESYE31 15784, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Ole-4, a novel synthetic derivative of Oleuropein, enhances antitumor immunity and modulates kinase activity-dependent signaling.

Ole-4, a novel synthetic derivative of Oleuropein, enhances antitumor immunity and modulates kinase activity-dependent signaling.

Journal: Journal of translational medicine

Published: October 13, 2025

ERAP1 Allotypes 2 and 10 Differentially Regulate the Immunopeptidome of Melanocytes.

ERAP1 Allotypes 2 and 10 Differentially Regulate the Immunopeptidome of Melanocytes.

Journal: Immunology

Published: July 31, 2025

Ole-Oxy, a Semi-Synthetic Analog of Oleuropein, Ameliorates Acute Skin and Colon Inflammation in Mice.

Ole-Oxy, a Semi-Synthetic Analog of Oleuropein, Ameliorates Acute Skin and Colon Inflammation in Mice.

Journal: Antioxidants (Basel, Switzerland)

Published: October 11, 2024

TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin.

TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin.

Journal: Cancers

Published: October 04, 2024

Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors.

Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors.

Journal: PloS one

Published: March 06, 2024

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

Journal: American journal of hematology

Published: March 04, 2024

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

Journal: Blood cancer journal

Published: August 28, 2023

Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients.

Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients.

Journal: American journal of hematology

Published: October 26, 2022

Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.

Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 30, 2022

Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo Investigation.

Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo Investigation.

Journal: Current medicinal chemistry

Published: September 07, 2021

4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, Greece.

4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, Greece.

Journal: Frontiers in bioscience (Landmark edition)

Published: July 15, 2021

Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

Journal: Cancers

Published: June 09, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026